By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere today reported that its first-quarter revenues declined, as contract revenue from the first quarter of 2010 was much higher than in 2011, but its product sales increased 31 percent.

The Northbrook, Ill.-based molecular diagnostics firm brought in total revenues of $640,000 for the three-month period ended March 31, down from $826,000 for Q1 2010. Nanosphere missed analysts' consensus estimate for revenues of $940,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.